Tango Therapeutics, Inc. TNGX
$24.24
-0.86%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-09-24 | View → |
| 4 | 4 | 2026-09-03 | View → |
| 8-K | 8-K | 2026-08-11 | View → |
| 424B5 | 424B5 | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-11 | View → |
| 10-Q | 10-Q | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | 4 | 2026-08-05 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 8-K | 8-K | 2026-06-23 | View → |
| 8-K | 8-K | 2026-06-10 | View → |
| 424B5 | 424B5 | 2026-06-10 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 424B5 | 424B5 | 2026-06-08 | View → |
| 8-K | 8-K | 2026-06-08 | View → |
| 8-K | 8-K | 2026-06-04 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 8-K | 8-K | 2026-05-13 | View → |
| 10-Q | 10-Q | 2026-05-13 | View → |
| 8-K | 8-K | 2026-05-08 | View → |
| 4 | 4 | 2026-05-05 | View → |
| 4 | 4 | 2026-05-05 | View → |
| 4 | 4 | 2026-05-01 | View → |
| DEF 14A | DEF 14A | 2026-04-17 | View → |
| 4 | 4 | 2026-04-16 | View → |
| 8-K | 8-K | 2026-04-15 | View → |
| 4 | 4 | 2026-04-02 | View → |
| 4 | 4 | 2026-03-27 | View → |
| 4 | 4 | 2026-03-09 | View → |
| 8-K | 8-K | 2026-03-05 | View → |
| 10-K | 10-K | 2026-03-05 | View → |
| 4 | 4 | 2026-02-27 | View → |
| 4 | 4 | 2026-02-04 | View → |
| 4 | 4 | 2026-02-04 | View → |
| 4 | 4 | 2026-02-04 | View → |
| 4 | 4 | 2026-01-12 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $24.24
- Market Cap
- $4.12 billion
- 52-Week Range
- $6.25 – $34.39
- Average Volume
- 2.74 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.